About
Spermosens AB is a Swedish medical technology company based in Lund, specializing in diagnostic healthcare products for male infertility. Founded in 2018, the company focuses on improving fertility treatment outcomes through innovative solutions. The core product, JUNO-Checked, is a diagnostic device that measures the interaction between sperm and egg cells. This technology allows for a more tailored selection of fertility treatments, particularly in the in vitro fertilization (IVF) market. By providing insights into sperm-egg binding, Spermosens aids fertility specialists in making informed treatment decisions. Spermosens serves fertility clinics and healthcare providers in reproductive medicine, enhancing their ability to manage male infertility effectively. The company is publicly traded on the Nordic Growth Market under the ticker symbol SPERM and has a small team of around four employees.
Technologies
Keywords
Company Information
- Employees3
- Founded2018
Location
2 Scheelevaegen, Lund, Skane County, Sweden, 223 49